1. Home
  2. TNXP vs WHF Comparison

TNXP vs WHF Comparison

Compare TNXP & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$13.30

Market Cap

220.5M

Sector

Health Care

ML Signal

HOLD

WHF

WhiteHorse Finance Inc.

HOLD

Current Price

$7.09

Market Cap

162.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNXP
WHF
Founded
2007
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
220.5M
162.5M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
TNXP
WHF
Price
$13.30
$7.09
Analyst Decision
Buy
Sell
Analyst Count
1
2
Target Price
$70.00
$7.75
AVG Volume (30 Days)
274.8K
125.1K
Earning Date
06-10-2026
01-01-0001
Dividend Yield
N/A
14.78%
EPS Growth
91.75
N/A
EPS
N/A
N/A
Revenue
$13,107,000.00
N/A
Revenue This Year
$7.00
N/A
Revenue Next Year
$708.37
N/A
P/E Ratio
N/A
$15.35
Revenue Growth
29.85
N/A
52 Week Low
$13.07
$6.07
52 Week High
$69.65
$10.48

Technical Indicators

Market Signals
Indicator
TNXP
WHF
Relative Strength Index (RSI) 35.02 56.28
Support Level N/A $6.79
Resistance Level $20.36 $7.24
Average True Range (ATR) 0.71 0.24
MACD 0.01 0.07
Stochastic Oscillator 10.23 66.34

Price Performance

Historical Comparison
TNXP
WHF

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About WHF WhiteHorse Finance Inc.

WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.

Share on Social Networks: